Budesonide
Brands: Pulmicort Respules · Budesonide
11 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it11 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 7 | SUPPLYING |
| Sandoz Inc | unknown | 3 | SUPPLYING |
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
| AstraZeneca Pharmaceuticals LP | unknown | 3 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | unknown | 2 | SUPPLYING |
| Chartwell RX, LLC | unknown | 2 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
| American Health Packaging | unknown | 1 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 29, 2026RECALLRecall (Class II): Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 po…
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide within the United States
- Jan 11, 2013RECALLRecall (Class III): PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04
Does Not Meet Monograph: Budesonide may be slightly above or below the specification range. — Recalling firm: AstraZeneca LP — Nationwide
- Jan 11, 2013RECALLRecall (Class III): PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension (30 ampules/carton) NDC: 0186-1988-04
Does Not Meet Monograph: Budesonide may be slightly above or below the specification range. — Recalling firm: AstraZeneca LP — Nationwide
Pill